Epstein Secrets

te: • Approve Amended and Restated License and Software Development Agreement with D.E. Shaw Research, LLC (Attachment 2) • Approve Yvonne Tran as Company's Corporate Secretary (Attachment 2) 3. Updates and Presentations: • Update on Company application for approximately $5.4 million grant from Bill &

o Attachment 2: Proposed stock option awards 4. Exhibit B to Attachment 2: Amended and Restated License and Software Development Agreement between Schrodinger, LLC and D.L. Shaw Research, LLC 5. Attachment 3: Financial Statements for Q I, FY 2013 6. Attachment 4: Financial Presentation If you have any ue

RESOLVED, that the Board hereby determines, in reliance on the Valuation Firm's written report, that the current fair market value per share of the Company's Common Stock is $0.21; RESOLVED FURTHER, that each individual named in Table 1 attached hereto be, and such individual hereby is, granted an option

(by phone) 1. Call to Order. A meeting of the Board of Directors of Schrodinger, Inc. (the "Board"), a Delaware corporation, (the "Company" or "Schrodinger") was held at the above place and time. Mr. Ardai, presiding as Chairman of the meeting, conducted a roll call and confirmed that Mr. Nikolic, Mr.

RESOLVED, that the Board hereby determines, in reliance on the Valuation Firm's written report, that the current fair market value per share of the Company's Common Stock is $0.21; RESOLVED FURTHER, that each individual named in Exhibit A attached hereto be, and such individual hereby is, granted an opti

utions and evidence the stock option grants. 2. Amended and Restated License and Software Development Agreement — D.E. Shaw Research, LLC WHEREAS, Schrodinger, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company, wishes to enter into an Amended and Restated License and